BridgeBio Pharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Palo Alto, CA
BBIO chart
What traders are saying about $BBIO
Latest postsBridgeBio Pharma, Inc. news
- Global Gene Therapy for Hearing Loss Market Report 2026 | Capture Growth to $1.71B by 2030 as Regeneron, Lilly, Sensorion and Astellas Advance AAV, CRISPR and Cochlear Delivery
Yahoo Finance ·
- BridgeBio to Participate in November and December Investor Conferences
Yahoo Finance ·
- BridgeBio’s management team has four fireside chats scheduled in London, Miami and New York.
Stock Titan ·
- BridgeBio Pharma, Inc. (BBIO) options chain
Yahoo Finance Australia ·
- How Investors Are Reacting To BridgeBio Pharma (BBIO) Stronger Quarterly Results
Simply Wall St ·
- BridgeBio Pharma xStock Price, BBIOX Price, Live Charts, and Marketcap - Coinbase Spain
Coinbase ·
- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- BridgeBio Pharma (BBIO) Cut Losses And Grew Revenue, Is The Stock Still Undervalued?
Simply Wall St ·
- BridgeBio Pharma stock nears key BBP-418 FDA decision
ad-hoc-news.de ·
- At $72.85 a share, BridgeBio Pharma (BBIO) executive sells 2,000 shares under a trading plan.
Stock Titan ·
- BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026
Yahoo Finance ·
- BridgeBio Pharma (NasdaqGS:BBIO) Stock Forecast & Analyst Predictions
Simply Wall St ·
BridgeBio Pharma, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $502.1M | $221.9M | $9.3M | $77.6M |
| Diluted EPS | $-3.78 | $-2.88 | $-3.95 | $-3.26 |
| Total assets (year end) | $936.0M | $919.3M | $546.4M | $623.0M |
| Cash and equivalents (year end) | $570.1M | $681.1M | $375.9M | $376.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BridgeBio Pharma, Inc.
- Ticker
- BBIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Palo Alto, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1743881
- Former names
- BridgeBio Pharma LLC
Frequently asked questions
What exchange is BridgeBio Pharma, Inc. listed on?
BridgeBio Pharma, Inc. trades on the Nasdaq under the ticker symbol BBIO.
What industry is BridgeBio Pharma, Inc. in?
BridgeBio Pharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is BridgeBio Pharma, Inc. headquartered?
BridgeBio Pharma, Inc.'s business address on file with the SEC is in Palo Alto, CA.
When does BridgeBio Pharma, Inc.'s fiscal year end?
BridgeBio Pharma, Inc.'s fiscal year ends on December 31.
How much revenue did BridgeBio Pharma, Inc. report?
BridgeBio Pharma, Inc. reported $502.1M in revenue for calendar year 2025, according to its SEC filings.